This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Askat Inc., Raqualia Pharma Inc., Arrys Therapeutics, Inc.. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nagoya, JP (2021)
- Aichi, JP (2014 - 2023)
Company Filing History:
5 out of 15 
2 out of 47 
1 out of 1 Years Active: 2014-2023
Title: Yukinori Take: Innovating Cancer Treatments Through Patents
Introduction
Yukinori Take is a prominent inventor based in Aichi, Japan, known for his significant contributions to the field of medical innovation, particularly in cancer treatment. With a total of seven patents to his name, his work focuses on developing compounds that target specific receptors involved in cancer progression.
Latest Patents
Among Yukinori Take's latest inventions is a selective EP4 receptor antagonistic substance aimed at treating cancer. This groundbreaking invention provides a medicament that significantly reduces cancer symptoms. It involves the use of a compound characterized by its inhibitory activities against the prostaglandin E2 receptor (EP4). These compounds are represented by various general formulas and can include pharmaceutically acceptable salts or compositions for medicinal use. The invention further outlines a method for administering these compounds to humans or animals, potentially in combination with other active agents.
Another noteworthy patent from Take involves the use of EP4 inhibitors as part of an immuno-oncology treatment strategy. This patent emphasizes the importance of an agent that inhibits EP4 activity, showcasing its application alongside immuno-oncology agents or related compositions for effective cancer treatment.
Career Highlights
Yukinori Take's professional journey includes pivotal roles in notable companies, such as Askat Inc. and Raqualia Pharma Inc. His extensive experience in these organizations has aided his development of innovative therapies aimed at addressing challenging medical conditions, particularly cancer.
Collaborations
Throughout his career, Yukinori has collaborated with distinguished colleagues, including Takako Okumura and Shinichi Koizumi. These partnerships have fostered a dynamic research environment, allowing for the exchange of ideas and advancements in cancer treatment methodologies.
Conclusion
Yukinori Take’s contributions to medical innovations, particularly in the realm of cancer therapy, reflect his dedication and expertise as an inventor. With a portfolio of impactful patents, he continues to inspire advancements in the treatment of cancer, paving the way for future discoveries and improvements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile